
VirginieBrosF
@virginiebrosf
CEO of @eurordis.
ID: 1813221827147411456
https://www.eurordis.org/staff/virginie-bros-facer/ 16-07-2024 14:39:30
16 Tweet
13 Followers
61 Following

Today in Brussels, EURORDIS President @avrilbdaly, CEO VirginieBrosF and Public Affairs Director Valentina Bottarelli handed the #ECRD2024 Open Letter, with over 2,000 signatures, to Stella Kyriakides. 🗣️ Read the full statement from the meeting: go.eurordis.org/s2FDEr

An encouraging discussion with Stella Kyriakides on the future of rare disease policymaking over the next five years covering numerous topics relevant to our community including the expansion of newborn screening!



We had the pleasure of meeting with several MEPs during today’s @Europarl_en Plenary Session, to discuss their commitment to our community and our joint priorities at the start of the new mandate. 🤝 MEP András Kulja, Stine Bosse / Christine, Vlad Voiculescu, Vytenis Andriukaitis, @tomislavsokol


How can Europe stay competitive? Harmonised reimbursement for rare disease treatment access. Speaking on the recent Draghi report, VirginieBrosF emphasised the importance of equal access to treatments, regardless of location.

Where there’s a will there’s a way! ✊@HU24EU The time is NOW for a European Action Plan on Rare Diseases and only by coming together can create lasting change for the 30 million people living with a rare disease in Europe. VirginieBrosF

Speaking this morning on the importance of rare disease policy planning, our CEO VirginieBrosF laid out the three key components needed to take the EU Action Plan from an idea to reality.

At POLITICOEurope Health Summit, VirginieBrosF met with Stella Kyriakides who called for the continued building of a robust European Health Union that supports all EU citizens, including those with rare diseases, and making sure the health budget remains strong in the next cycle.


🗣️ "When we care, and when we show that we care, we will achieve far more than we ever thought possible." - VirginieBrosF Explore how we will be continuing to advance diagnosis, treatment access, and rare disease care in the year to come. 📖 go.eurordis.org/iSX2Vp
